1. Market Research
  2. > Healthcare Market Trends
Healthcare Infrastructure in Nigeria, Key Opportunities 2017–2020

Healthcare Infrastructure in Nigeria, Key Opportunities 2017–2020

  • December 2017
  • 77 pages
  • ID: 5281662
  • Format: PDF

Summary

Table of Contents

Rapid Urbanization, Growing Disposable Income, and Expanding Health Insurance Coverage Will Raise the Demand for Quality Specialty Care Throughout the Forecast Period
Nigeria has the largest consumer base in Sub-Saharan region. A larger part of the population living in urban areas is a favorable indicator for market entry.

Robust growth of around 7% for the past decade is threatened by macroeconomic challenges, particularly exchange-rate volatility and falling global oil prices that impact public-sector spending. Nigeria is the most populated country in the African continent with a population of approximately 186 million in 2016. The mixture of a large population, a swelling middle class with the capability to pay for services, an increasing demand for specialist facilities, and high-quality care which is evident from the large number of outbound medical tourists from the country.

Despite the fact that a vast segment of Nigeria’s population utilizes private health services and spends an enormous out-of-pocket share toward health expenditures, a sizable part of it is spent on low-quality services and products.

Also, the unavailability of consistent and timely data on the Nigerian health sector for decision making pushes companies intending to invest in Nigeria to conduct a thorough market assessment for the specific products and services they plan to bring in. In order to harness the resources in both the public and the private healthcare sectors in Nigeria, the country has developed a National Policy on public private partnerships for health, aligned with the National Health Policy.

The importance of public private partnerships is increasing due to the revitalization of the healthcare industry and the new hospital market, with the government often providing land for the project as well as security for investments.

Nigeria suffers a heavy burden of infectious diseases, particularly malaria, and experiences frequent outbreaks of water-borne diseases such as cholera, which in some instances, requires hospitalization. Additionally, Nigeria has been witnessing an increase in the incidence of non-communicable diseases, which often lead to hospitalization if the condition is not well-managed.

This increase in incidence of chronic and infectious diseases sets up an immense pressure to diagnose and treat faster and in a cost-effective manner. This makes requires a transformation of the healthcare infrastructure in Nigeria. This research intends to provide a clear indication of the current healthcare landscape in Nigeria as well as the level of development that currently exists in this market.

The research service will highlight some key areas for investment in Nigeria, while many industries are still in a latent stage of development. In this way, the research service can begin to answer questions regarding the time horizon for future investment in key supporting industries such as private hospitals, health insurance, and more specialized devices, pharmaceuticals, and healthcare services.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2019 Global HIV/AIDS Diagnostics Market: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Strategies

2019 Global HIV/AIDS Diagnostics Market: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Strategies

  • $ 3500
  • March 2019

2019 Global HIV/AIDS Diagnostics Market: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Sales Segment Forecasts, Innovative Technologies and Tests, Competitive StrategiesThe report presents ...

2019 Dry (Atrophic) Macular Degeneration Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Dry (Atrophic) Macular Degeneration Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019

The ongoing clinical trial research report- “2019 Dry (Atrophic) Macular Degeneration Ongoing Clinical Trials Study” analyzes the current scenario of all active Dry (Atrophic) Macular Degeneration ...

2019 Normal-Tension Glaucoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Normal-Tension Glaucoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019

The ongoing clinical trial research report- “2019 Normal-Tension Glaucoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Normal-Tension Glaucoma trials across the world. ...


ref:plp2017

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on